pargyline has been researched along with Muscle Disorders in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boegman, RJ | 1 |
| Wood, PL | 1 |
| Pinaud, L | 1 |
| Ranish, NA | 1 |
| Dettbarn, WD | 1 |
| Gross, S | 1 |
| Coleman, M | 1 |
| Randall, J | 1 |
3 other studies available for pargyline and Muscle Disorders
| Article | Year |
|---|---|
Increased axoplasmic flow associated with pargyline under conditions which induce a myopathy.
Topics: Animals; Axonal Transport; Leucine; Male; Muscular Diseases; Pargyline; Rats; Sciatic Nerve; Spinal | 1975 |
Myopathy-inducing drugs and fast axoplasmic transport.
Topics: Animals; Axonal Transport; Dose-Response Relationship, Drug; Male; Muscular Diseases; Paraoxon; Parg | 1977 |
Pargyline-induced myopathy in rats and vitamin B6.
Topics: Animals; Disease Models, Animal; Female; Magnesium; Muscles; Muscular Diseases; Pargyline; Pyridoxin | 1975 |